Form 4: Adaptive Biotechnologies Director Peter Neupert Exercises Options and Sells Shares
SEC Form 4 Filing
Director Peter Neupert of Adaptive Biotechnologies Corp. exercised stock options and sold shares on March 10, 2025.
Summary
- On March 10, 2025, Peter M Neupert, a director of Adaptive Biotechnologies Corporation, exercised stock options to acquire 50,000 shares of common stock at a price of $4.07 per share.
- Simultaneously, Neupert sold 10,000 shares of common stock at a weighted-average price of $7.05, with individual transactions ranging from $7.03 to $7.07.
- Following these transactions, Neupert directly owns 224,690 shares of Adaptive Biotechnologies Corp. common stock.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of insider trading activity. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, providing transparency to investors regarding the buying and selling activities of company directors. It's common for executives to exercise stock options and sell a portion of the acquired shares for personal financial management.
Key Dates
| Date | Description |
|---|---|
| 03/10/2025 | Date of transaction: exercise of stock options and sale of shares. |
| 03/12/2025 | Date of signature on the Form 4 filing. |
| 03/31/2025 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.